A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer.
一种新型的双特异性抗体药物偶联物，靶向 HER2 和 HER3，对乳腺癌具有强大的治疗效果
期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-024-01279-8
Zong Hui-Fang, Li Xi, Han Lei, Wang Lei, Liu Jun-Jun, Yue Ya-Li, Chen Jie, Ke Yong, Jiang Hua, Xie Yue-Qing, Zhang Bao-Hong, Zhu Jian-Wei
